Pablo Sánchez Vela
@sanchezvelamd
Physician-Scientist in the @RossLevineLab at @MSKCancerCenter. @TheMarkFdn Fellow. All these tweets only express my own opinions and not the previous.
ID: 1294741713467179010
15-08-2020 21:04:31
98 Tweet
393 Takipçi
1,1K Takip Edilen
Stromal mutations occur, but hard to prove they are functional. In our new paper with Trey Ideker’s lab and led by Dr. Mohita Tagore and Maayan Baron, we show that we can find these by looking for mutations across a “class” of genes rather than single genes: nature.com/articles/s4158…
Chairperson Manel Esteller is discussing the Epigenetic Hallmarks of Cancer now at the #AACR25 Education Session on the Evolution of Cancer Hallmarks - read the landmark review: brnw.ch/21wSeP3
Don't miss posters at #AACR25 starting now! Pablo Sánchez Vela will present a study that evaluated Tet2-mutant clonal hematopoiesis microenvironment enrichment as a driver of treatment resistance in #thyroidcancer. Memorial Sloan Kettering Cancer Center ASCO Learn more: bit.ly/4lXQUSL
Thanks to AACR and to the John Kincade fund for supporting our work! You are really making a difference! Awesome collaborative work with Memorial Sloan Kettering Cancer Center MSK Department of Medicine Memorial Sloan Kettering Biostatistics Service MSK Department of Pathology & Laboratory Medicine Vera Tiedje Ross Levine Lab
🚨 New research from MSK and Weill Cornell Medicine shows that BCG, the first FDA-approved cancer #immunotherapy, doesn't just act locally in the bladder. It travels to the bone marrow, where it reprograms and amplifies immune stem cells, boosting the body’s ability to fight cancer more
Congratulations on your #ASCO25 poster, Ariadna Roqué Lloveras!
We’re proud to partner with American Cancer Society to announce the recipients of the inaugural Leukemia Exploration And Prevention (LEAP) Team Grant. 𝘗𝘳𝘰𝘫𝘦𝘤𝘵: 𝘐𝘯𝘵𝘳𝘪𝘯𝘴𝘪𝘤 & 𝘦𝘹𝘵𝘳𝘪𝘯𝘴𝘪𝘤 𝘮𝘦𝘤𝘩𝘢𝘯𝘪𝘴𝘮𝘴 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘤𝘭𝘰𝘯𝘢𝘭 𝘧𝘪𝘵𝘯𝘦𝘴𝘴 𝘢𝘯𝘥
Dr. Ross Levine (Ross Levine), Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). Dr. Levine will be responsible for setting and leading strategy for basic and translational research, including programs, centers,
So many things to celebrate this week! Thank you everyone! and congrats Maite and Ross Levine!!
Researchers from Memorial Sloan Kettering Cancer Center have developed a proximity-tagging method to map molecules that associate in 3D space to better understand chromatin organization. Read more in @molecularcell #ASHG25 hubs.li/Q03P9XQm0
Little progress has been made in the treatment of anaplastic thyroid cancer Vera Tiedje Gnana Krishnamoorthy et al. Memorial Sloan Kettering Cancer Center now find mice with aggressive ATC respond to the inhibitor combination dabrafenib/trametinib by affecting cancer cell MHCII expression & increasing T-cell